Advertisement
Organisation › Details
Crelux GmbH
CRELUX (www.crelux.com) is a provider of high-quality solutions for early stage drug development. Its core expertise lies in the production of prime proteins and their use in biophysical screening and protein crystallography. The privately –owned company has itself established as a reliable premium provider for the global pharma and biotech industry. As a research partner CRELUX contributes a portfolio of state-of-the-art hit-finding, -validation and –optimization technologies along with top-level expertise in protein biochemistry. CRELUX markets its services under several brand names: innovations for the production of challenging to get proteins and protein complexes (PRIME PROTEINS), a wide selection of therapeutically relevant target proteins for X-ray crystallography (XPRESS portfolio), customised programmes for the solution of new protein structures (XPERT/XPEDITE) and innovative technologies for fragment and compound screening and biophysical validation (INTRACT). *
Start | 2005-02-01 established | |
Group | WuXi PharmaTech (Group) | |
Industry | protein crystallisation technology | |
Industry 2 | proteomic services | |
Person | Hager, Gundel (WuXi PharmaTec 201912 Managing Director at Crelux) | |
Person 2 | Moarefi, Ismail (Crelux 200502– co-founder) | |
Region | Martinsried | |
Country | Germany | |
Street | 19a Am Klopferspitz | |
City | 82152 Martinsried | |
Tel | +49-89-700760-170 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2005-06-17) |
* Document for »About Section«: | ||
Record changed: 2023-12-30 |
Advertisement
More documents for WuXi PharmaTech (Group)
- [1] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
- [2] Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development"....
- [3] Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY....
- [4] AC Immune S.A.. (12/19/18). "Press Release: AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership". Lausanne & Shanghai....
- [5] Probiodrug AG. (10/5/18). "Press Release: Probiodrug Reports Management Changes". Halle (Saale)....
- [6] Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale)....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top